
aug pm et
summari compani largest distributor health care product servic
office-bas dental medic veterinari practition
price-to-earnings oper ep
risk assess reflect histori consist
annual ebitda growth greater everi year sinc
stabl oper margin balanc
increas depend acquisit
sustain earn growth particularli organ growth
dental consum slow recent year
nov ep estim base cfra oper earn
histor earn report compani report
cash dividend paid last year
past perform indic futur perform reli upon
analysi prepar equiti analyst
aug stock trade
jun-q revenu adjust oper
profit growth yoy
respect howev view
result favor sever reason
pre-tax earn depreci
amort ebtda growth neg
inventori rise much faster
made annual acquisit averag
last year help
leverag support bolt-on
invest strategi think recur
natur warrant inclus restructur
debt cost assess hsic margin
growth respect account
factor estim jun-q ebitda margin fell
basi point yoy ebtda fell
yoy inventori turn jun-q fell
year ago feel
worth monitor import dental
lead market posit growth outlook
favor think quarter weaker
advertis margin pressur
continu
ep estim
remark steadi grower
posit revenu ebit growth everi year
sinc admir reliabl
compani lead market share
office-bas dental medic anim health
distribut remain cautiou share
mainli valuat reason ad
despit strong acceler sale
growth outlook back half
year temper august
largest
manufactur dental equip lower
sale guidanc bode well
hsic largest segment
risk view includ
weaker-than-expect demand end
market increas competit
e-commerc player on-go litig
target price
ev/ebitda multipl roughli in-lin hsic
near premium forward
outlook index
premium justifi opinion
premium magnitud guid view
share like fulli valu present
redistribut reproduct prohibit without written permiss copyright cfra document intend provid person invest advic take account specif invest
object financi situat particular need specif person may receiv report investor seek independ financi advic regard suitabl and/or appropri make
invest implement invest strategi discuss document understand statement regard futur prospect may realiz investor note incom
invest may fluctuat valu invest may rise fall accordingli investor may receiv back less origin invest investor seek advic concern impact
invest may person tax posit tax advisor pleas note public date document may contain specif inform longer current use make
invest decis unless otherwis indic intent updat document
senior vice presid
vice presid
corpor overview largest distributor health care product servic
office-bas health care practition compani suppli dental practic physician practic
veterinari clinic suppli might need dental handpiec anim pharmaceut
x-ray machin compani also provid practic manag softwar solut
hsic primari busi distribut segment account revenu
oper profit distribut includ dental product gener total sale
anim health product medic product distribut segment
achiev oper margin yoy oper profit growth two-third total sale
gener remaind intern
technolog segment primarili sell practic manag softwar dental veterinari medic
practic account revenu oper profit technolog segment
achiev oper margin y/i oper profit growth
market profil health care product distribut industri relat office-bas
practition encompass dental anim health medic market produc estim
revenu global compani estim due part inabl store manag larg
quantiti suppli offic distribut health care suppli small equip
office-bas practition character frequent small quantiti order need rapid
reliabl order fulfil
industri continu experi growth due age popul prolifer medic
technolog amongst expand global middl class increas health dental insur
coverag addit physician market continu benefit shift procedur
diagnost test acute-car set alternate-car site particularli physician offic
recent year seen health care industri increasingli focus cost contain
fuel growth hmo group practic collect buy group addit emphasi
obtain product competit price collabor tend favor distributor capabl
provid special manag inform support trend benefit distributor
provid broad array product low price technolog solut improv care deliveri
also led mani distributor limit financi oper market resourc combin
larger compani provid growth opportun
competit landscap compet highli fragment custom base
distributor well sever manufactur dental medic anim health product
sell direct end-us primari competit factor industri price breadth product line
custom servic market scale value-ad servic on-cal repair fleet practic
sale dental product primari competitor patterson benco dental suppli
anim health market primari competitor primari competitor
sale medic product medlin
corpor strategi sought continu expand product servic offer
domest intern acquisit dental anim health medic product
distributor smaller scale compani also activ acquir practic manag
softwar provid acquisit activ pick recent year total acquisit invest
made respect acquisit
support hsic three-year compound annual growth rate ebitda view posit
asset growth slightli outpac ebitda growth result compani maintain
ebitda/asset ratio ebtda/equ ratio improv bp due
use leverag acquisit
april compani announc anim health product distribut segment spun
merg vet first choic form independ public compani vet first choic current
provid technology-en solut prescript manag softwar veterinari
practition busi combin offer full rang anim health suppli value-ad
servic custom receiv tax-fre dividend part deal
sharehold new entiti base compani guidanc expect ebit margin
improv spin-off dont expect meaning
impact overal organ growth rate beyond anim segment organ revenu
growth materi differ segment transact expect
complet end
financi trend hsic compound annual growth rate revenu ebitda
normal ep grew period ep growth aid
common stock repurchas ebitda growth ebitda margin
in-lin averag previou five year view hsic balanc sheet favor net
debt/ebitda debt/asset march decemb
compani use leverag support multipl acquisit one potenti concern
monitor come quarter inventori turnov fell march quarter
averag last four year
redistribut reproduct prohibit without prior written permiss copyright cfra
base cfra proprietari quantit model
stock rank overvalu
analysi stock current worth base
cfra proprietari quantit model suggest
overvalu
bullish sinc june technic indic
bullish
figur base fiscal year-end price
growth rate averag
lt debt capit
return equiti
balanc sheet data million
oper
long term debt capit
net incom revenu
return asset
return equiti
 global market intellig data may preliminari restat result discontinu operations/speci item per share data adjust stock dividend ep dilut
redistribut reproduct prohibit without prior written permiss copyright cfra
pressur fee distributor receiv
supplier
contributor margin expans
cost control divestitur
under-perform unit profit
stock benefit acquisit
april health
distributor decreas vs
declin composit
sub-industri index fell
versu gain
fundament outlook health care
distributor sub-industri next
month neutral outlook base mainli
favor demand trend see drug
suppli segment gener compris
busi three larg
drug distributor make bulk
market-cap weight sub-industri index
partial off-set drug reimburs drug
price cost pressur expect
distributor benefit new gener
result patent expir mani
large-sel brand drug view
gener import drug distributor
carri wider margin brand
product howev note drug price inflat
like continu moder
restrict gross profit dollar growth
acquisit strateg partner
sector also increas
cardin
drug-sourc contract
caremark partnership support
improv purchas cost greater drug
purchas scale support improv gener
longer term expect larg
distributor realiz high-single-digit
annual ep gain benefit gener drug
penetr age popul drug price
inflat addit see near term
benefit increas american
cover health insur
afford act make
pharmaceut afford note
recent repeal individu mandat
result fewer live cover
next year also see distributor top
line pressur next year
patent loss sever blockbust drug
base index
five-year market price perform aug
note sector sub-industri inform base
past perform indic futur perform
reli upon
yield equiti
ltd
peer group compani stock select issu base market capit
note peer select base global industri classif standard market capit peer group list includ compani similar characterist may includ compani within
industri and/or engag line busi
redistribut reproduct prohibit without prior written permiss copyright cfra
merit intend defend vigor cfra legal edg note
case similar previou feder case firm concern
alleg sourceon end settlement believ
case could materi financi impact /keith snyder
inc keep target
ep estim multipl line three-year forward averag price-to-earnings
balanc improv sale growth outlook expect flat margin
expans impact increas sale low-margin product trim
ep estim
report oper ep vs consensu
sale increas driven growth global dental expect
sale growth reflect continu strength intern
et cfra keep hold opinion share henri schein inc
maintain target price
ep estim multipl compar five-year
histor averag price-to-earnings reflect improv sale growth outlook
expect stabl margin level report oper ep
vs consensu sale increas
growth dental segment driven growth market
expect sale growth aid tuck-in acquisit
market-shar gain strong organ growth anim health segment /k
rais target
ep estim compar three-year forward averag price-to-earnings
reflect improv sale growth outlook rais
ep estim report
oper ep vs consensu sale
increas driven growth dental segment expect
sale growth aid acquisit expect new three-year
 distribut agreement
accret earn /k snyder
analyst research note compani news
sell hold lower target price
forward price-to-earnings steep discount pdco long-term averag
think discount justifi neg earn growth trend
recent year see abat continu lose market share
lower fy apr ep estim
despit acquisit fy pdco earn
tax amort ebta fell yoy fy
fy respect also despit absorb lower margin organ growth
dental consum sale neg last quarter
competitor posit growth
suspect greater focu cross-sel softwar solut suppli
equip import factor market share gain
note term practic manag
softwar appear time recent earn call
versu note ad relat topic
inc keep target price
ev/ebitda multipl roughli line long-term averag rais
ep estim ep
vs consensu report market share
gain help acceler jun-q sale growth yoy year ago
note howev growth pre-tax earn deprec amortiz
ebtda slow yoy due lower margin higher
interest expens despit strong pickup revenu growth
full-year guidanc rais think indic
continu margin pressur second half view market posit
growth outlook favor expect ebtda growth versu
remain cautiou share howev estim trade
premium forward ev/ebitda despit slower
growth outlook index /colin scarola
inc trim target price
ep estim slight discount three-year forward averag
price-to-earnings keep ep estim lower
report oper ep vs
consensu sale increas growth dental
increas anim health driven strong result intern market
announc spin anim health segment merg
sharehold approxim new compani vet first
choic sharehold own pend transact subject customari
close condit regulatori approv expect close end
view posit given unlock consider valu
inc keep target ep
estim compar five-year forward averag price-to-earnings balanc
improv sale growth outlook expect modest margin
compress due higher restructur cost rais ep estim
set report oper ep
vs line consensu sale increas
growth dental driven growth intern market see
sale growth aid acquisit stabl market share
inc announc su ftc along
patterson benco dental suppli alleg conspiraci refus provid
discount compet busi buy group repres
dental practition compani believ alleg without
note research note reflect cfra publish opinion analysi stock time note publish note reflect view equiti analyst date time
indic note may reflect cfra current view compani
redistribut reproduct prohibit without prior written permiss copyright cfra
fiscal year analyst estim earn
usd quarter fiscal year
announc earn per share usd repres
total revenu estim fiscal year
analyst estim earn per share grow
usd
total
estimate
forecast reliabl indic futur perform
note compani earn outlook play major part invest decis global market intellig organ earn estim wall street analyst
provid consensu earn next two year well earn estim chang time note inform provid relat consensu
estim intend predict actual result taken reliabl indic futur perform
note tabl graph chart report cite refer sourc sourc global market intellig
redistribut reproduct prohibit without prior written permiss copyright cfra
sinc januari cfra equiti fund research servic
predecessor capit iq equiti research rank univers
common stock adr american depositari receipt adss american
depositari share base given equiti potenti futur perform
similarli rank asian european equiti sinc june
rank equiti accord individu forecast equiti futur total
return potenti versu expect total return relev benchmark
region index asia europ
base time horizon star design meet need
investor look put invest decis perspect data use
assist determin star rank may result analyst
model well intern proprietari model result dynam data
also known
 growth
stabil earn dividend deem key element establish
global market intellig earn dividend rank common stock
design capsul natur record singl symbol
note howev process also take consider certain
adjust modif deem desir establish rank
final score stock measur score matrix determin
analysi score larg repres sampl stock
rang score array sampl align follow
ladder rank
cfra earn per share ep estim reflect analyst project futur
ep continu oper gener exclud variou item
view special non-recur extraordinari also ep estim reflect
either forecast equiti analyst consensu averag ep estim
independ compil global market intellig data
provid cfra among item typic exclud ep estim
asset sale gain impair restructur merger-rel charg legal
insur settlement process research develop expens gain
loss extinguish debt cumul effect account
chang earn relat oper classifi
compani discontinu inclus item stock option
expens recur type charg may vari depend
factor industri practic analyst judgment extent
type data disclos compani
equiti analyst project market price given secur command
month henc base combin intrins rel privat
cfra equiti research produc distribut account research
analyt llc d/b/a cfra cfra us togeth affili
subsidiari cfra certain research produc distribut cfra
sdn bhd compani formerli known standard poor
malaysia sdn bhd cfra malaysia certain research distribut cfra uk
limit cfra uk cfra uk cfra malaysia wholly-own subsidiari
cfra us
abbrevi use equiti research report
ebit earn interest tax
redistribut reproduct prohibit without prior written permiss copyright cfra
p/nav price net asset valu ratio price-to-earnings-to-growth ratio pv present
 research develop roce return capit employ roe
return equiti
roi return invest
 return invest capit
roa return asset
wacc weight averag capit
dividend american depositori receipt adr american depositori
share adss net tax paid countri origin
reflect equiti analyst view given compani oper risk
risk firm abil continu on-going concern qualit risk
assess rel rank star univers
reflect risk factor relat compani oper oppos risk
volatil measur associ share price etf reflect
capitalization-weight basi averag qualit risk assess
assign hold fund
star rank system definit
total return expect outperform total return relev benchmark
notabl margin come month share rise price
total return expect outperform total return relev benchmark
come month share rise price absolut basi
total return expect close approxim total return relev
benchmark come month share gener rise price
absolut basi
total return expect under-perform total return relev
benchmark come month share price anticip
total return expect under-perform total return relev
benchmark notabl margin come month share fall
price absolut basi
north america relev benchmark europ
asia relev benchmark europ asia
